Literature DB >> 18980215

TGF-beta1 induces rearrangement of FLK-1-VE-cadherin-beta-catenin complex at the adherens junction through VEGF-mediated signaling.

Brandoch D Cook1, Giovanni Ferrari, Giuseppe Pintucci, Paolo Mignatti.   

Abstract

VEGF and TGF-beta1 induce angiogenesis but have opposing effects on vascular endothelial cells: VEGF promotes survival; TGF-beta1 induces apoptosis. We have previously shown that TGF-beta1 induces endothelial cell apoptosis via up-regulation of VEGF expression and activation of signaling through VEGF receptor-2 (flk-1). In context with TGF-beta1, VEGF signaling is transiently converted from a survival into an apoptotic one. VEGF promotes cell survival in part via activation of PI3K/Akt by a mechanism dependent on the formation of a multi-protein complex that includes flk-1 and the adherens junction proteins VE-cadherin and beta-catenin. Here we report that TGF-beta1 induces rearrangement of the adherens junction complex by separating flk-1 from VE-cadherin and increasing beta-catenin association with both flk-1 and VE-cadherin. This rearrangement is caused neither by changes in adherens junction mRNA or protein expression nor by post-translational modification, and requires VEGF signaling through flk-1. These results show that the adherens junction is an important regulatory component of TGF-beta1-VEGF interaction in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980215      PMCID: PMC2588645          DOI: 10.1002/jcb.21935

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  48 in total

Review 1.  FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition.

Authors:  M J Cross; L Claesson-Welsh
Journal:  Trends Pharmacol Sci       Date:  2001-04       Impact factor: 14.819

Review 2.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Regulation of E-cadherin/Catenin association by tyrosine phosphorylation.

Authors:  S Roura; S Miravet; J Piedra; A García de Herreros; M Duñach
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

4.  Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.

Authors:  Inmaculada Segura; Antonio Serrano; Gonzalo González De Buitrago; Manuel A González; Jose Luis Abad; Cristina Clavería; Lucio Gómez; Antonio Bernad; Carlos Martínez-A; Hans H Riese
Journal:  FASEB J       Date:  2002-06       Impact factor: 5.191

5.  The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.

Authors:  S Hofmann; H Grasberger; P Jung; M Bidlingmaier; J Vlotides; O E Janssen; R Landgraf
Journal:  Eur J Med Res       Date:  2002-04-30       Impact factor: 2.175

6.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

7.  Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.

Authors:  T P Quinn; K G Peters; C De Vries; N Ferrara; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

8.  VE-cadherin is a critical endothelial regulator of TGF-beta signalling.

Authors:  Noemi Rudini; Angelina Felici; Costanza Giampietro; MariaGrazia Lampugnani; Monica Corada; Kendra Swirsding; Massimiliano Garrè; Stefan Liebner; Michelle Letarte; Peter ten Dijke; Elisabetta Dejana
Journal:  EMBO J       Date:  2008-03-13       Impact factor: 11.598

Review 9.  The splice variants of vascular endothelial growth factor (VEGF) and their receptors.

Authors:  C J Robinson; S E Stringer
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

10.  Evidence that tyrosine phosphorylation may increase tight junction permeability.

Authors:  J M Staddon; K Herrenknecht; C Smales; L L Rubin
Journal:  J Cell Sci       Date:  1995-02       Impact factor: 5.285

View more
  8 in total

Review 1.  Endothelial permeability and VE-cadherin: a wacky comradeship.

Authors:  Julie Gavard
Journal:  Cell Adh Migr       Date:  2013-12-05       Impact factor: 3.405

2.  Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.

Authors:  Qiang Sun; Shu Guo; Chen-Chao Wang; Xu Sun; Di Wang; Nan Xu; Shi-Feng Jin; Ke-Zhu Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Stroma regulates increased epithelial lateral cell adhesion in 3D culture: a role for actin/cadherin dynamics.

Authors:  Karen F Chambers; Joanna F Pearson; Naveed Aziz; Peter O'Toole; David Garrod; Shona H Lang
Journal:  PLoS One       Date:  2011-04-18       Impact factor: 3.240

Review 4.  Endothelial permeability and VE-cadherin: a wacky comradeship.

Authors:  Julie Gavard
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

5.  Detection of p53 and Bcl-2 expression in cutaneous hemangioma through the quantum dot technique.

Authors:  Tian Tang; Duan-Lian Zhang
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

6.  Growth differentiation factor 11 promotes differentiation of MSCs into endothelial-like cells for angiogenesis.

Authors:  Chi Zhang; Yinuo Lin; Qi Liu; Junhua He; Pingping Xiang; Dianliang Wang; Xinyang Hu; Jinghai Chen; Wei Zhu; Hong Yu
Journal:  J Cell Mol Med       Date:  2020-06-25       Impact factor: 5.310

7.  Two-stage degradation and novel functional endothelium characteristics of a 3-D printed bioresorbable scaffold.

Authors:  Tieying Yin; Ruolin Du; Yang Wang; Junyang Huang; Shuang Ge; Yuhua Huang; Youhua Tan; Qing Liu; Zhong Chen; Hanqing Feng; Jie Du; Yazhou Wang; Guixue Wang
Journal:  Bioact Mater       Date:  2021-08-24

8.  TGF-β1 induces the formation of vascular-like structures in embryoid bodies derived from human embryonic stem cells.

Authors:  Yan Wang; DE-Jian Qian; Wen-Yu Zhong; Jun-Hong Lu; Xiang-Kai Guo; Yi-Lin Cao; Ju Liu
Journal:  Exp Ther Med       Date:  2014-05-19       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.